missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Serpin A3/alpha 1-Antichymotrypsin Antibody (5G3C11) - BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody has been used in 1 publication
Brand: Novus Biologicals NBP2-52559-0.025mg
This item is not returnable.
View return policy
Description
Serpin A3/alpha 1-Antichymotrypsin Monoclonal specifically detects Serpin A3/alpha 1-Antichymotrypsin in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, CyTOF-ready.
Specifications
| Serpin A3/alpha 1-Antichymotrypsin | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot 1:500-1:2000, Flow Cytometry 1:200-1:400, ELISA 1:10000, Immunohistochemistry 1:200-1:1000, Immunohistochemistry-Paraffin, CyTOF-ready | |
| AACTMGC88254, ACTGIG25, alpha-1-antichymotrypsin, antitrypsin), member 3, Cell growth-inhibiting gene 24/25 protein, growth-inhibiting protein 24, growth-inhibiting protein 25, member 3, serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, serine (or cysteine) proteinase inhibitor, clade A, member 3, Serpin A3, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) | |
| Mouse | |
| 47.7 kDa | |
| 0.025 mg | |
| Breast Cancer, Cancer | |
| 12 | |
| Human | |
| Purified |
| Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin), CyTOF | |
| 5G3C11 | |
| Unconjugated | |
| PBS with 0.05% Sodium Azide | |
| SERPINA3 | |
| Purified recombinant fragment of human SERPINA3 (AA: 279-432) expressed in E. Coli. | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
| Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction